A WHO Reference Reagent for lupus (anti-dsDNA) antibodies: International collaborative study to evaluate a candidate preparation

Bernard J. Fox, Jason Hockley, Peter Rigsby, Carl Dolman, Pier Luigi Meroni, Johan Rönnelid

Research output: Contribution to journalArticle

Abstract

Introduction Antibodies against double-stranded DNA (anti-dsDNA) are a specific biomarker for systemic lupus erythematosus (SLE). The first WHO International Standard (IS) for anti-dsDNA (established in 1985), which was used to assign units to diagnostic tests, was exhausted over a decade ago. Methods Plasma from a patient with SLE was first evaluated in 42 European laboratories. The plasma was thereafter used by the National Institute for Biological Standards and Control to prepare a candidate WHO reference preparation for lupus (anti-dsDNA) antibodies. That preparation, coded 15/174, was subjected to an international collaborative study, including 36 laboratories from 17 countries. Results The plasma mainly contained anti-dsDNA, other anti-chromatin antibodies and anti-Ku. The international collaborative study showed that the field would benefit from 15/174 as a common reference reagent improving differences in performance between different assays. However, no statistically meaningful overall potency or assay parallelism and commutability could be shown. Conclusion 15/174 cannot be considered equivalent to the first IS for anti-dsDNA (Wo/80) and was established as a WHO Reference Reagent for lupus (oligo-specific) anti-dsDNA antibodies with a nominal value of 100 units/ampoule. This preparation is intended to be used to align test methods quantifying levels of anti-dsDNA antibodies.

Original languageEnglish
Pages (from-to)1677-1680
Number of pages4
JournalAnnals of the Rheumatic Diseases
Volume78
Issue number12
DOIs
Publication statusPublished - Dec 1 2019

Fingerprint

Antibodies
DNA
Plasmas
Systemic Lupus Erythematosus
Assays
Biomarkers
Routine Diagnostic Tests
Chromatin
Anti-Idiotypic Antibodies

Keywords

  • autoantibodies
  • autoimmune diseases
  • systemic lupus erythematosus

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

A WHO Reference Reagent for lupus (anti-dsDNA) antibodies : International collaborative study to evaluate a candidate preparation. / Fox, Bernard J.; Hockley, Jason; Rigsby, Peter; Dolman, Carl; Meroni, Pier Luigi; Rönnelid, Johan.

In: Annals of the Rheumatic Diseases, Vol. 78, No. 12, 01.12.2019, p. 1677-1680.

Research output: Contribution to journalArticle

Fox, Bernard J. ; Hockley, Jason ; Rigsby, Peter ; Dolman, Carl ; Meroni, Pier Luigi ; Rönnelid, Johan. / A WHO Reference Reagent for lupus (anti-dsDNA) antibodies : International collaborative study to evaluate a candidate preparation. In: Annals of the Rheumatic Diseases. 2019 ; Vol. 78, No. 12. pp. 1677-1680.
@article{3721944c653548c3a8aed45b0d1c4e4b,
title = "A WHO Reference Reagent for lupus (anti-dsDNA) antibodies: International collaborative study to evaluate a candidate preparation",
abstract = "Introduction Antibodies against double-stranded DNA (anti-dsDNA) are a specific biomarker for systemic lupus erythematosus (SLE). The first WHO International Standard (IS) for anti-dsDNA (established in 1985), which was used to assign units to diagnostic tests, was exhausted over a decade ago. Methods Plasma from a patient with SLE was first evaluated in 42 European laboratories. The plasma was thereafter used by the National Institute for Biological Standards and Control to prepare a candidate WHO reference preparation for lupus (anti-dsDNA) antibodies. That preparation, coded 15/174, was subjected to an international collaborative study, including 36 laboratories from 17 countries. Results The plasma mainly contained anti-dsDNA, other anti-chromatin antibodies and anti-Ku. The international collaborative study showed that the field would benefit from 15/174 as a common reference reagent improving differences in performance between different assays. However, no statistically meaningful overall potency or assay parallelism and commutability could be shown. Conclusion 15/174 cannot be considered equivalent to the first IS for anti-dsDNA (Wo/80) and was established as a WHO Reference Reagent for lupus (oligo-specific) anti-dsDNA antibodies with a nominal value of 100 units/ampoule. This preparation is intended to be used to align test methods quantifying levels of anti-dsDNA antibodies.",
keywords = "autoantibodies, autoimmune diseases, systemic lupus erythematosus",
author = "Fox, {Bernard J.} and Jason Hockley and Peter Rigsby and Carl Dolman and Meroni, {Pier Luigi} and Johan R{\"o}nnelid",
year = "2019",
month = "12",
day = "1",
doi = "10.1136/annrheumdis-2019-215845",
language = "English",
volume = "78",
pages = "1677--1680",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "12",

}

TY - JOUR

T1 - A WHO Reference Reagent for lupus (anti-dsDNA) antibodies

T2 - International collaborative study to evaluate a candidate preparation

AU - Fox, Bernard J.

AU - Hockley, Jason

AU - Rigsby, Peter

AU - Dolman, Carl

AU - Meroni, Pier Luigi

AU - Rönnelid, Johan

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Introduction Antibodies against double-stranded DNA (anti-dsDNA) are a specific biomarker for systemic lupus erythematosus (SLE). The first WHO International Standard (IS) for anti-dsDNA (established in 1985), which was used to assign units to diagnostic tests, was exhausted over a decade ago. Methods Plasma from a patient with SLE was first evaluated in 42 European laboratories. The plasma was thereafter used by the National Institute for Biological Standards and Control to prepare a candidate WHO reference preparation for lupus (anti-dsDNA) antibodies. That preparation, coded 15/174, was subjected to an international collaborative study, including 36 laboratories from 17 countries. Results The plasma mainly contained anti-dsDNA, other anti-chromatin antibodies and anti-Ku. The international collaborative study showed that the field would benefit from 15/174 as a common reference reagent improving differences in performance between different assays. However, no statistically meaningful overall potency or assay parallelism and commutability could be shown. Conclusion 15/174 cannot be considered equivalent to the first IS for anti-dsDNA (Wo/80) and was established as a WHO Reference Reagent for lupus (oligo-specific) anti-dsDNA antibodies with a nominal value of 100 units/ampoule. This preparation is intended to be used to align test methods quantifying levels of anti-dsDNA antibodies.

AB - Introduction Antibodies against double-stranded DNA (anti-dsDNA) are a specific biomarker for systemic lupus erythematosus (SLE). The first WHO International Standard (IS) for anti-dsDNA (established in 1985), which was used to assign units to diagnostic tests, was exhausted over a decade ago. Methods Plasma from a patient with SLE was first evaluated in 42 European laboratories. The plasma was thereafter used by the National Institute for Biological Standards and Control to prepare a candidate WHO reference preparation for lupus (anti-dsDNA) antibodies. That preparation, coded 15/174, was subjected to an international collaborative study, including 36 laboratories from 17 countries. Results The plasma mainly contained anti-dsDNA, other anti-chromatin antibodies and anti-Ku. The international collaborative study showed that the field would benefit from 15/174 as a common reference reagent improving differences in performance between different assays. However, no statistically meaningful overall potency or assay parallelism and commutability could be shown. Conclusion 15/174 cannot be considered equivalent to the first IS for anti-dsDNA (Wo/80) and was established as a WHO Reference Reagent for lupus (oligo-specific) anti-dsDNA antibodies with a nominal value of 100 units/ampoule. This preparation is intended to be used to align test methods quantifying levels of anti-dsDNA antibodies.

KW - autoantibodies

KW - autoimmune diseases

KW - systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=85072014517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072014517&partnerID=8YFLogxK

U2 - 10.1136/annrheumdis-2019-215845

DO - 10.1136/annrheumdis-2019-215845

M3 - Article

C2 - 31488407

AN - SCOPUS:85072014517

VL - 78

SP - 1677

EP - 1680

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 12

ER -